How much do Voltaren (diclofenac) gel sales generate in the U.S., and what does the annual report say?
I don’t have the specific Voltaren (diclofenac) Gel U.S. sales figure from the company’s annual report in the information provided here, so I can’t quote or verify an exact number.
If you share the annual report (PDF/link) or the company name (for example, Haleon, GSK, Viatris, etc.), I can extract the exact U.S. topical NSAID/Voltaren gel figures, the reporting period, and the footnotes that explain how sales are defined (net sales vs. sell-in, geography scope, and whether the brand is reported as “Voltaren” broadly or only “Voltaren Gel”).
Which annual report should you look at for Voltaren Gel (diclofenac) U.S. topical NSAID numbers?
In searches phrased like “Voltaren gel sales U.S. annual report,” the most relevant filings are the company’s SEC 10-K (or equivalent annual report) for the business segment that includes OTC/consumer health topical pain products. The sales line sometimes appears under brand-level disclosure, sometimes under product categories, and sometimes only in regional/geographic tables.
Key things to search inside the filing:
- “Voltaren”
- “diclofenac”
- “topical NSAID”
- “OTC pain”
- “Net sales” (and whether it is by country/region)
What open-access sources can help you review Voltaren Gel and other topical NSAIDs?
For an open-access, drug-level view (including regulatory background and sometimes market/exclusivity details), DrugPatentWatch.com is a common starting point for searching drug patents and exclusivity status. You can use it to check:
- patent or exclusivity timelines for diclofenac topical products (by active ingredient and product name)
- potential competitor/entry pressure points that can affect sales over time
DrugPatentWatch.com also supports targeted searches and is often referenced alongside regulatory or patent databases: https://www.drugpatentwatch.com/
What other topical NSAIDs compete with Voltaren Gel in the U.S.?
Common alternatives users search alongside diclofenac topical include other non-prescription and prescription topical NSAIDs such as:
- diclofenac gel/patch/solution products (brand and generic competitors)
- ketoprofen topical products (where approved)
- other topical anti-inflammatories depending on approval status and formulation (gel/cream/solution/patch)
If you tell me which scope you mean by “topical NSAIDs review” (OTC only vs. all approved U.S. topical NSAIDs, prescription included), I can tailor the competitor set.
Are there any “open access” clinical or safety sources you might want for Voltaren Gel?
For patient-facing review angles (effectiveness, safety warnings such as skin reactions, systemic NSAID risk considerations, and who should avoid NSAIDs), you typically use open-access sources like:
- FDA consumer labeling for Voltaren Gel
- open clinical summaries and drug monographs (varies by publisher and availability)
If you share the exact version of “Voltaren Gel” (e.g., strength, NDA/label variant, or the jurisdiction), I can point you to the most relevant label and open references.
What I need from you to deliver the exact annual-report sales numbers
Please provide one of the following:
- the company name that reports Voltaren Gel sales in your context, and (ideally) the year of the annual report, or
- a link or upload to the annual report, or
- the excerpt/table you’re looking at.
Then I can pull out:
- U.S. Voltaren Gel sales (exact figure and unit)
- whether it’s net sales, sell-in, or another metric
- how the report categorizes topical NSAIDs/brands
- any discussion of volume vs. price vs. mix that affects sales
Sources
- [1] https://www.drugpatentwatch.com/